Legal & General Group’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$121K Sell
61,591
-17,230
-22% -$40.4K ﹤0.01% 2593
2025
Q4
$214K Hold
78,821
﹤0.01% 2578
2025
Q3
$333K Hold
78,821
﹤0.01% 2537
2025
Q2
$393K Buy
78,821
+21,607
+38% +$93.8K ﹤0.01% 2509
2025
Q1
$252K Hold
57,214
﹤0.01% 2577
2024
Q4
$266K Hold
57,214
﹤0.01% 2629
2024
Q3
$397K Hold
57,214
﹤0.01% 2535
2024
Q2
$446K Hold
57,214
﹤0.01% 2454
2024
Q1
$406K Sell
57,214
-8,541
-13% -$56.5K ﹤0.01% 2508
2023
Q4
$441K Buy
65,755
+4,802
+8% +$27K ﹤0.01% 2506
2023
Q3
$343K Buy
60,953
+12,823
+27% +$85.5K ﹤0.01% 2580
2023
Q2
$266K Buy
48,130
+26,896
+127% +$145K ﹤0.01% 2674
2023
Q1
$133K Buy
21,234
+2,634
+14% +$14.7K ﹤0.01% 2716
2022
Q4
$86.7K Hold
18,600
﹤0.01% 2845
2022
Q3
$87K Sell
18,600
-13,026
-41% -$82.1K ﹤0.01% 2860
2022
Q2
$187K Buy
+31,626
New +$352K ﹤0.01% 2658

Other funds holding GDRX

Legal & General Group's GDRX Position: Q1 2026 in Review

Legal & General Group reduced its GoodRx Holdings (GDRX) stake by 22% in Q1 2026, selling an estimated $40.4K and leaving 61,591 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #2593.

Legal & General Group first reported a position in GDRX in Q2 2022 and has held it in 16 quarters since. The position peaked at $446K in Q2 2024. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Legal & General Group held 61,591 shares of GoodRx Holdings worth $121K as of Q1 2026.
  • Legal & General Group sold 17,230 GoodRx Holdings shares in Q1 2026, an estimated $40.4K.
  • GoodRx Holdings made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2593 holding.
  • Legal & General Group first reported a position in GoodRx Holdings in Q2 2022 and has held it in 16 quarters since.
  • Legal & General Group's GoodRx Holdings position peaked at $446K in Q2 2024.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.